Savara (SVRA) Current Assets (2010 - 2026)
Savara (SVRA) reported Current Assets of $209.3 million for Q1 2026, up 17.93% year-over-year from $177.4 million in Q1 2025, and down 13.39% quarter-over-quarter from $241.6 million in Q4 2025.
Savara (SVRA) Current Assets (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Current Assets data on file, last reported at $209.3 million in Q1 2026.
- Current Assets for Q1 2026 came in at $209.3 million, up 17.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $209.3 million (up 17.93% YoY), and the FY2025 annual result was $241.6 million, up 19.53% from the prior year.
- Current Assets fell to $209.3 million in Q1 2026 per SVRA's latest filing, from $241.6 million in the prior quarter.
- Over five years, Current Assets peaked at $241.6 million in Q4 2025 and troughed at $107.9 million in Q2 2023.
- A 5-year average of $161.0 million and a median of $151.0 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets surged 33.1% in 2024, then plunged 43.37% in 2025.
- A 5-year view of Current Assets shows it stood at $129.0 million in 2022, then gained by 28.69% to $165.9 million in 2023, then increased by 21.81% to $202.1 million in 2024, then climbed by 19.53% to $241.6 million in 2025, then slipped by 13.39% to $209.3 million in 2026.
- Business Quant data shows SVRA's Current Assets at $209.3 million in Q1 2026, $241.6 million in Q4 2025, and $128.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 209.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.27 Mn |
| Dec 31, 2025 | 241.62 Mn |
| Sep 30, 2025 | 128.20 Mn |
| Jun 30, 2025 | 150.99 Mn |
| Mar 31, 2025 | 177.44 Mn |
| Dec 31, 2024 | 202.14 Mn |
| Sep 30, 2024 | 226.40 Mn |
| Jun 30, 2024 | 127.69 Mn |
| Mar 31, 2024 | 146.19 Mn |
| Dec 31, 2023 | 165.95 Mn |
| Sep 30, 2023 | 170.10 Mn |
| Jun 30, 2023 | 107.90 Mn |
| Mar 31, 2023 | 117.63 Mn |
| Dec 31, 2022 | 128.95 Mn |
| Sep 30, 2022 | 137.07 Mn |
| Jun 30, 2022 | 145.39 Mn |
| Mar 31, 2022 | 154.54 Mn |
| Dec 31, 2021 | 165.00 Mn |
| Sep 30, 2021 | 174.58 Mn |
| Jun 30, 2021 | 183.49 Mn |